Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Burosumab in Children and Adolescents With XLH
NCT04419363Phase 4Unknown
- Sponsor
- Hôpital Bicêtre
- Start
- Mar 2018
- Primary completion
- Mar 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of burosumab in X-linked hypophosphatemia (XLH), sponsored by Hôpital Bicêtre. Status: unknown.
02
Drugs
burosumab
03
Conditions
X-linked hypophosphatemia (XLH)
Beyond the preview
Go deeper on NCT04419363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04419363.